Bio-rad Laboratories, Inc. Earnings

Bio-rad Laboratories, Inc.’s revenue jumped 2.79% since last year same period to $649.73Mn in the Q3 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 1.76% jump in its revenue since last 3-months.

Bio-rad Laboratories, Inc.’s net profit jumped 514.71% since last year same period to $653.17Mn in the Q3 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 130.16% jump in its net profits since last 3-months.

Bio-rad Laboratories, Inc.’s net profit margin jumped 498.05% since last year same period to 100.53% in the Q3 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 129.64% jump in its net profit margins since last 3-months.

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.16 - a -42.29% fall from last quarter’s estimates.

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 1.16.

Bio-rad Laboratories, Inc.’s earning per share (EPS) fell -13.73% since last year same period to 2.01 in the Q3 2024. This indicates that the Bio-rad Laboratories, Inc. has generated -13.73% annual rate of fall in its earning per share (EPS) in the last 4 quarters.